...
首页> 外文期刊>Logopedics, phoniatrics, vocology. >Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson’s disease as measured with a portable voice accumulator
【24h】

Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson’s disease as measured with a portable voice accumulator

机译:用便携式语音蓄能器测量的帕金森病的日常声音对日常声音使用的长期影响

获取原文
获取原文并翻译 | 示例
           

摘要

This study examines the effects of an intensive voice treatment focusing on increasing voice intensity, LSVT LOUD??Lee Silverman Voice Treatment, on voice use in daily life in a participant with Parkinson’s disease, using a portable voice accumulator, the VoxLog. A secondary aim was to compare voice use between the participant and a matched healthy control. Participants were an individual with Parkinson’s disease and his healthy monozygotic twin. Voice use was registered with the VoxLog during 9?weeks for the individual with Parkinson’s disease and 2?weeks for the control. This included baseline registrations for both participants, 4 weeks during LSVT LOUD for the individual with Parkinson’s disease and 1 week after treatment for both participants. For the participant with Parkinson’s disease, follow-up registrations at 3, 6, and 12 months post-treatment were made. The individual with Parkinson’s disease increased voice intensity during registrations in daily life with 4.1?dB post-treatment and 1.4?dB at 1-year follow-up compared to before treatment. When monitored during laboratory recordings an increase of 5.6?dB was seen post-treatment and 3.8?dB at 1-year follow-up. Changes in voice intensity were interpreted as a treatment effect as no significant correlations between changes in voice intensity and background noise were found for the individual with Parkinson’s disease. The increase in voice intensity in a laboratory setting was comparable to findings previously reported following LSVT LOUD. The increase registered using ambulatory monitoring in daily life was lower but still reflecting a clinically relevant change.
机译:本研究审查了强化语音治疗的影响,重点关注语音强度,LSVT响亮的声音,LEE SILVERMAN语音治疗,在与帕金森病的参与者中的日常生活中使用,使用便携式的语音蓄能器,VoxLog。二次目的是比较参与者与匹配的健康控制之间的语音使用。参与者是帕金森病的个人和他健康的单义双胞胎。在9月9日为帕金森病的疾病和2个星期进行了voxlog注册了语音用途。这包括两个参与者的基线注册,在LSVT在LSVT响亮的情况下为帕金森病的疾病和治疗后1周的一名参与者。对于帕金森病的参与者,进行3,6和12个月的后续登记。帕金森病的个体在日常生活中的注册期间增加了语音强度,治疗后4.1℃,与治疗前的1年后的1.4 dB。当实验室记录期间监测时,在治疗后的增加5.6?DB和3.8?DB在1年后续行动。语音强度的变化被解释为治疗效果,因为帕金森病的个体没有发现语音强度和背景噪声之间的显着相关性。实验室设置中的语音强度的增加与先前在LSVT大声之后报告的结果相当。在日常生活中使用外影监测的增加的增加较低,但仍在反映临床相关的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号